Cargando…
The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells
Emerging evidence demonstrates that platelet-derived growth factor-D (PDGF-D) plays a critical role in epithelial-mesenchymal transition (EMT) and drug resistance in hepatocellular carcinoma (HCC) cells. However, the underlying mechanism has not been fully elucidated. The objective is to explore the...
Autores principales: | Wang, Rui, Li, Yumei, Hou, Yueyue, Yang, Qingling, Chen, Sulian, Wang, Xi, Wang, Zishu, Yang, Yan, Chen, Changjie, Wang, Zhiwei, Wu, Qiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466665/ https://www.ncbi.nlm.nih.gov/pubmed/25760076 |
Ejemplares similares
-
Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway
por: Wu, Qiong, et al.
Publicado: (2013) -
MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells
por: Yang, Qingling, et al.
Publicado: (2014) -
MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells
por: Liu, Yang, et al.
Publicado: (2016) -
The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1
por: Wu, Haihua, et al.
Publicado: (2018) -
NT21MP negatively regulates paclitaxel-resistant cells by targeting miR-155-3p and miR-155-5p via the CXCR4 pathway in breast cancer
por: Wang, Yueyue, et al.
Publicado: (2018)